FundedIQ

Recently Funded Biotechnology Startups in Philadelphia

Updated Aug 2026

There are 32 funded Biotechnology startups in Philadelphia in the FundedIQ database, each with its funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in Philadelphia, along with the 32 most recently funded Biotechnology startups in Philadelphia.

The median disclosed round is $8.0M, with the middle half of rounds falling between $4.1M and $67M. Biotechnology startups in Philadelphia closed 14 funding rounds over the last 24 months, 6 of them in the last 12 months, and raised $532M in disclosed capital.

Local venture capital and strategic funds dominate these checks. The lean staffing levels across the segment indicate a heavy reliance on external research partners. Firms like Flagship Pioneering steer the direction of these ventures. This concentration of institutional backing means a high barrier for entry and a preference for deep technical validation over general commercial appeal.

Biotechnology funded startup statistics in Philadelphia

Funded Biotechnology startups in Philadelphia
32
tracked in the database
Funding rounds, last 12 months
6
14 over 24 months
Disclosed capital raised, 24 months
$532M
13 of 14 rounds disclosed an amount
Median round size
$8.0M
middle half $4.1M to $67M

Most recent funding round on record: Jul 2026.

32 most recently funded Biotechnology startups in Philadelphia

32 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

F
Philadelphia, United States · Biotechnology
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional…
Series D ·
$67M
T
Tolerance Bio
Philadelphia, United States · Biotechnology
Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to…
Seed ·
Undisclosed
C
Philadelphia, United States · Biotechnology
Children's Brain Tumor Network provides data resources and supports research on pediatric brain tumors.
Series Unknown ·
$10k
C
Philadelphia, United States · Biotechnology
Cabaletta Bio is a biopharmaceutical company that specializes in developing cellular therapies for autoimmune…
Series Unknown ·
$150M
V
Philadelphia, United States · Biotechnology
Verismo Therapeutics creates new chimeric antigen receptors (CARs) that improve T-cell-based immunotherapy…
Series Unknown ·
$28M
C
Philadelphia, United States · Biotechnology
Century Therapeutics creates a platform for cell therapy using allogeneic iPSC-derived cells that combine…
Series Unknown ·
$135M
V
Philadelphia, United States · Biotechnology
Vetigenics develops new immunotherapies for treating cancer and chronic conditions in dogs, which do not have…
Seed ·
$6.0M
A
Philadelphia, United States · Biotechnology
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
Series A ·
$28M
I
Philadelphia, United States · Biotechnology
Integral Molecular's goal is to develop and employ innovative technologies to facilitate the discovery of…
Series Unknown ·
$8.0M
E
Philadelphia, United States · Biotechnology
EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders. Our…
Series Unknown ·
$280k
S
Philadelphia, United States · Biotechnology
Strella biotech is a revenue-generating food supply chain company that provides data to optimize the produce…
Series Unknown ·
$5.6M
N
Philadelphia, United States · Biotechnology
NephroDI Therapeutics is a biopharmaceutical company in Philadelphia, Pennsylvania that specializes in kidney…
Series Unknown ·
$2.0M
I
Philadelphia, United States · Biotechnology
Imvax is a biotech firm that specializes in creating innovative vaccines and immunotherapy methods for…
Series Unknown ·
$35M
C
Philadelphia, United States · Biotechnology
Context Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel treatments for…
Series Unknown ·
$100M
B
Biomeme
Philadelphia, United States · Biotechnology
Biomeme is a mobile PCR thermocycler that connects to an iPhone 5s to allow for DNA diagnostics and real-time…
·
Undisclosed
E
Philadelphia, United States · Biotechnology
We are a clinical stage biopharmaceutical company engaged in the discovery and development of synthetic…
Series Unknown ·
$5.1M
A
Philadelphia, United States · Biotechnology
Aro Biotherapeutics, a biotech company located in Philadelphia, is at the forefront of advancing the…
Series B ·
$42M
V
Philadelphia, United States · Biotechnology
Vivodyne expedites the process of finding remedies for human diseases by conducting large-scale drug tests on…
Seed ·
$38M
A
Philadelphia, United States · Biotechnology
A specialty oncology-focused biopharmaceutical company with a large pipeline of novel small molecules and…
Series Unknown ·
$5.0M
N
Philadelphia, United States · Biotechnology
National Disease Research Interchange is the source of human tissues, cells and organs for scientific…
Series Unknown ·
$14M
V
Philadelphia, United States · Biotechnology
VintaBio provides pharmaceutical and biotechnology companies with manufacturing services for cell and gene…
Series Unknown ·
$64M
K
Philadelphia, United States · Biotechnology
Venture - Series Unknown ·
$1.2M
C
Philadelphia, United States · Biotechnology
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology…
Series C ·
$30M
A
Philadelphia, United States · Biotechnology
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform in the…
Grant ·
$400k
P
Philadelphia, United States · Biotechnology
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's…
Seed ·
$3.2M
W
Philadelphia, United States · Biotechnology
The Wistar Institute is the nation’s first independent institution devoted to medical research and training.…
Grant ·
$5.0M
A
Avammune Therapeutics
Philadelphia, United States · Biotechnology
Avammune Therapeutics is a medication revelation organization zeroed in on immuno-oncology and particularly…
Venture - Series Unknown ·
Undisclosed
H
Philadelphia, United States · Biotechnology
Corona Labs (previously Optofluidics) is an endeavor upheld logical instrumentation organization that markets…
Series C ·
$6.0M
H
Philadelphia, United States · Biotechnology
Hale Therapeutics, a Philadelphia firm developing a nicotine vaporizer designed to wean smokers and vapers…
Angel ·
$200k
I
Philadelphia, United States · Biotechnology
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high…
Series A ·
$50M
N
Philadelphia, United States · Biotechnology
Navrogen Inc. is a biopharmaceutical company focused on the targeted treatment of cancer. Navrogen is…
Seed ·
$3.0M
C
Philadelphia, United States · Biotechnology
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The…
Series C ·
$160M

Funding stages of funded Biotechnology startups in Philadelphia

How the last 24 months of funding rounds for funded Biotechnology startups in Philadelphia break down by stage.

Stage
Rounds, last 24 months

A further 9 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in Philadelphia

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 32 funded Biotechnology startups in Philadelphia currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (1 of 14 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in Philadelphia is dated Jul 2026.

The table above shows the 32 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in Philadelphia?

FundedIQ tracks 32 funded Biotechnology startups in Philadelphia. This page lists the 32 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in Philadelphia raised?

Biotechnology startups in Philadelphia tracked by FundedIQ have raised $532M in disclosed capital across 14 funding rounds over the last 24 months, including 6 rounds in the last 12 months. 13 of those 14 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in Philadelphia?

The median disclosed round over the last 24 months is $8.0M, and the middle half of rounds fall between $4.1M and $67M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in Philadelphia?

Seed is the most common labelled stage, with 3 rounds in the last 24 months, ahead of Series A (1) and Series D (1). A further 9 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in Philadelphia updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in Philadelphia is dated Jul 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.